PMID- 15242752 OWN - NLM STAT- MEDLINE DCOM- 20050113 LR - 20141120 IS - 0016-6480 (Print) IS - 0016-6480 (Linking) VI - 138 IP - 1 DP - 2004 Aug TI - Environmental estrogens can affect the function of mussel hemocytes through rapid modulation of kinase pathways. PG - 58-69 AB - Estrogens and estrogenic chemicals can affect several vertebrate non-reproductive functions, the immune response in particular. We have previously shown that in the hemocytes of the marine mollusc Mytilus the natural estrogen 17beta-estradiol (E(2)) can affect the immune function through rapid tyrosine kinase-mediated signalling pathways converging on phosphorylation of both mitogen activated protein kinases (MAPKs) and signal transducers and activators of transcription (STATs), whose activation plays a key role in the immune response. In this work the effects of synthetic estrogens (such as DES), estrogenic chemicals (such as Bisphenol A, Nonylphenol), and plant estrogens (genistein) on mussel hemocytes were evaluated. The results demonstrate that all the EDCs tested exert in vitro effects similar to those of E(2) on lysosomal membrane stability, although at concentrations 1000 times higher than those of the natural estrogen. When the effects of DES, BPA, and NP on tyrosine kinase-mediated cell signalling were investigated, estrogenic compounds showed distinct effects on the phosphorylation state of MAPK and STAT members. In particular, only DES, like E(2), induced p38 MAPK phosphorylation, whereas BPA and NP seem to have opposite effects. Moreover, different EDCs significantly decreased the tyrosine phosphorylation state of STAT3 and STAT5, showing a distinct effect with respect to E(2). Experiments with specific kinase inhibitors showed that activation of p38 MAPK, but also of ERK MAPK and PI3-kinase, plays a key role in mediating the effect of DES. On the other hand, the effects of NP were partly mediated by ERK MAPK activation. BPA-induced lysosomal membrane destabilisation was unaffected by either MAPK or PI3-K inhibitors. However, hemocyte pre-treatment with the PKC inhibitor GF109203X prevented the effects of both BPA and NP, this indicating that kinase pathways other than those involving MAPKs are also responsible for mediating the effects of certain EDCs. Overall, the results support the hypothesis that EDCs may rapidly modulate the function of mussel hemocytes through activation of transduction pathways involving different kinase-mediated cascades. Moreover, the effects of EDCs on the phosphorylation state of transcription factor STATs suggest that these compounds may lead to changes in gene expression secondary to modulation of kinase/phosphatases. Our data address to the importance of investigating full range responses to estrogenic chemicals and may help understanding their basic mechanisms of action in ecologically relevant invertebrate species. FAU - Canesi, Laura AU - Canesi L AD - Istituto di Scienze Fisiologiche, Universita di Urbino, "Carlo Bo," Loc. Crocicchia, 61029 Urbino, Italy. canesi@uniurb.it FAU - Lorusso, Lucia Cecilia AU - Lorusso LC FAU - Ciacci, Caterina AU - Ciacci C FAU - Betti, Michele AU - Betti M FAU - Zampini, Massimiliano AU - Zampini M FAU - Gallo, Gabriella AU - Gallo G LA - eng PT - Journal Article PL - United States TA - Gen Comp Endocrinol JT - General and comparative endocrinology JID - 0370735 RN - 0 (Estradiol Congeners) RN - 0 (Estrogens, Non-Steroidal) RN - EC 2.7.- (Phosphotransferases) RN - EC 2.7.11.24 (Mitogen-Activated Protein Kinases) SB - IM MH - Animals MH - Bivalvia/*physiology MH - Cells, Cultured MH - Estradiol Congeners/pharmacology MH - Estrogens, Non-Steroidal/*pharmacology MH - Hemocytes/drug effects/enzymology/*physiology MH - In Vitro Techniques MH - Intracellular Membranes/drug effects/metabolism MH - Lysosomes/drug effects MH - Mitogen-Activated Protein Kinases/metabolism MH - Phosphorylation MH - Phosphotransferases/*physiology EDAT- 2004/07/10 05:00 MHDA- 2005/01/14 09:00 CRDT- 2004/07/10 05:00 PHST- 2004/02/26 00:00 [received] PHST- 2004/04/13 00:00 [revised] PHST- 2004/05/13 00:00 [accepted] PHST- 2004/07/10 05:00 [pubmed] PHST- 2005/01/14 09:00 [medline] PHST- 2004/07/10 05:00 [entrez] AID - S0016648004001339 [pii] AID - 10.1016/j.ygcen.2004.05.004 [doi] PST - ppublish SO - Gen Comp Endocrinol. 2004 Aug;138(1):58-69. doi: 10.1016/j.ygcen.2004.05.004.